Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto vs Enalapril in Japanese HFrEF (PARALLEL-HF)
NCT02468232Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sacubitril + valsartan in heart failure with reduced ejection fraction (HFrEF), sponsored by Novartis. Started Jun 2015; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT02468232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468232.